Ovarian Hyperstimulation: Diagnosis, Prevention, and Management

Author(s):  
Paolo Emanuele Levi-Setti ◽  
Noemi Di Segni ◽  
Clara Gargasole ◽  
Camilla Ronchetti ◽  
Federico Cirillo

AbstractOvarian hyperstimulation syndrome (OHSS) is a severe complication of controlled ovarian stimulation (COS). Pathogenesis of the disease is based on massive transudation of protein-rich fluid from the vascular compartment into the peritoneal, pleural and pericardial spaces, with a variable picture of clinical manifestations depending on its severity. Nowadays OHSS can easily be avoided by several prevention methods, ranging from identification of high-risk patients, choice of a correct protocol stimulation, trigger with gonadotropin-releasing hormone (GnRH) agonists or, finally, the freeze-all strategy. When OHSS occurs, it can usually be managed as outpatient care. Only if severe/critical cases are diagnosed hospitalization is necessary for appropriate rehydration, monitoring of fluid balance and eventual drainage of ascitic fluid. One of the most dangerous complications of OHSS is venous thromboembolism (VTE). Thromboprophylaxis has shown to be cost effective and widely used, while there are controversies regarding the usage of low dose aspirin (LDA) as a preventive measure.

2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Dagmar Wertaschnigg ◽  
Maya Reddy ◽  
Ben W. J. Mol ◽  
Fabricio da Silva Costa ◽  
Daniel L. Rolnik

In this review, we discuss the recent literature regarding the prevention of preeclampsia and aim to answer common questions that arise in the routine antenatal care of pregnant women. Prescription of low-dose aspirin for high-risk patients has been shown to reduce the risk of preeclampsia (PE). A daily dose between 100 and 150 mg taken in the evening should be initiated prior to 16 weeks of gestation and can be continued until delivery. Calcium supplementation seems to be advantageous but currently it is only considered for patients with poor dietary intake and high risk for PE. Recent data about heparin are still conflicting, and therefore, heparin can currently not be recommended in the prevention of PE.


2008 ◽  
Vol 89 (4) ◽  
pp. 1035-1036 ◽  
Author(s):  
Ákos Várnagy ◽  
Miklos Koppan ◽  
Zoltan Manfai ◽  
Csaba Busznyak ◽  
Jozsef Bodis

Stroke ◽  
2006 ◽  
Vol 37 (2) ◽  
pp. 447-451 ◽  
Author(s):  
Hiroshi Sato ◽  
Kinji Ishikawa ◽  
Akira Kitabatake ◽  
Satoshi Ogawa ◽  
Yukio Maruyama ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document